Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
Amene Saghazadeh, Nima Rezaei
Topics & Concepts
TocilizumabMedicineCoronavirus disease 2019 (COVID-19)ImmunologyAntibodyCytokine stormImmune systemCytokineMonoclonal antibodyCytokine release syndromeInterleukin 6DiseaseInternal medicineInfectious disease (medical specialty)Rheumatoid arthritisCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19